PDCD1 and neoplasm: They discovered a significant reduction in granulocyte/macrophage progenitors (GMP) in PD-1-deficient mice, and myeloid cells of tumor-bearing mice were skewed toward the LY6C+ monocytic lineage, which was determined by myeloid-PD-1 deletion.